Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

TGM3 is important for skin and hair structure and may help diagnose cancer.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The reviewers found the manuscript on inflammation's role in cancer stem cells to be relevant but suggested it needs clarity, more background information, discussion on immune cells' role in tumors, updated references, and grammar corrections.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

A new method accurately measures cell changes in breast cancer.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

The reviewers suggest clarifying and expanding on the role of inflammation in stem cell-related cancer development.

The reviewers suggest major revisions for clarity and inclusion of recent findings on inflammation's role in cancer.

Reviewers suggest clarifying the abstract, adding background on inflammation's effect on cancer, discussing immune cell roles, including counter studies, and correcting grammar.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Early detection and complete surgical removal are crucial for better outcomes in treating pilomatrix carcinoma.

EPDS can cause recurring scalp sores and hair loss if not treated.

Porocarcinoma generally has low rates of recurrence, spread to lymph nodes, and death.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.